Toward Objective Anal Cancer Screening: From Swab‐Based Genome‐Wide Methylation Marker Discovery to Novel Test Development
International Journal of Cancer · 01.01.2027 · 160 (1) · 187-200
DOI: 10.1002/ijc.70708 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 27.08.2026. Verfasst von Kirsten Rozemeijer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Anus Neoplasms, DNA Methylation, Biomarkers, Tumor, Early Detection of Cancer. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Economic Affairs, Dutch Cancer Society, Stichting NEXTGEN HIGHTECH Program.
Abstract (Originalsprache)
Anal high‐grade squamous intraepithelial lesions (HSIL:AIN2/3) are precursors to anal cancer, and early detection and treatment through screening is crucial for effective cancer prevention. Current guidelines recommend anal swab‐based screening and highlight the need for objective biomarkers to improve risk stratification. While DNA methylation markers have shown strong potential in anal biopsies, their performance in anal swabs is reduced, likely due to sample‐type dependency. This study aimed to identify a DNA methylation classifier specifically derived from anal swabs of men who have sex with men living with HIV (MSMLWH) to enhance diagnostic accuracy. Genome‐wide methylation profiling was performed on anal swabs from 36 HSIL:AIN3 cases, 34 controls (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
- Department of Epidemiology and Data Science, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Public Health, Amsterdam, the Netherlands.
- Department of Dermatology, University of Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
- Self-Screen B.V., Amsterdam, the Netherlands.
ORCID-Profile: Kirsten Rozemeijer, Fernando Dias Gonçalves Lima, Albertus T Hesselink, Chris J L M Meijer, Jan M Prins, Henry J C de Vries, Mark A van de Wiel, Renske D M Steenbergen
Förderung
- Ministry of Economic Affairs
- Dutch Cancer Society
- Stichting NEXTGEN HIGHTECH Program
- Stichting Hanarth Fonds
- KWF Kankerbestrijding
- Hanarth Fonds
Zitieren
APA
Rozemeijer, K., Claesen, J., Dias Gonçalves Lima, F., Hesselink, A. T., Klingers, P., Ter Braak, T., van den Burgt, Y., Meijer, C. J. L. M., Prins, J. M., de Vries, H. J. C., van de Wiel, M. A., & Steenbergen, R. D. M. (2027). Toward Objective Anal Cancer Screening: From Swab‐Based Genome‐Wide Methylation Marker Discovery to Novel Test Development. International Journal of Cancer, 160(1), 187-200. https://doi.org/10.1002/ijc.70708
Vancouver
Rozemeijer K, Claesen J, Dias Gonçalves Lima F, Hesselink AT, Klingers P, Ter Braak T, et al. Toward Objective Anal Cancer Screening: From Swab‐Based Genome‐Wide Methylation Marker Discovery to Novel Test Development. International Journal of Cancer. 2027;160(1):187-200. doi:10.1002/ijc.70708
BibTeX
@article{Rozemeijer2027,
author = {Rozemeijer, Kirsten and Claesen, Jürgen and Dias Gonçalves Lima, Fernando and Hesselink, Albertus T and Klingers, Phoebe and Ter Braak, Timo and van den Burgt, Yara and Meijer, Chris J L M and Prins, Jan M and de Vries, Henry J C and van de Wiel, Mark A and Steenbergen, Renske D M},
title = {Toward Objective Anal Cancer Screening: From Swab‐Based Genome‐Wide Methylation Marker Discovery to Novel Test Development},
journal = {International Journal of Cancer},
year = {2027},
volume = {160},
number = {1},
pages = {187--200},
doi = {10.1002/ijc.70708}
}
EUVIMED